Erik Harris
CIK 1780113 · EVP & Chief Commercial Officer · last filed 2026-04-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.34M
Companies
4
Total Filings
31
Lifetime Open-Market Net
-$2.66M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RARE | EVP & Chief Commercial Officer | 118,410 | $24.35 | $2.88M | -$2.66M | 25 | 2026-04-20 |
| RZLT | Director | 21,000 | $4.00 | $84.0K | $0 | 2 | 2025-11-21 |
| Inozyme Pharma, Inc. (INZY) Delisted | Director | — | $4.00 | — | $0 | 1 | 2024-10-07 |
| DNLI | Director | 17,052 | $21.66 | $369.3K | $0 | 3 | 2024-06-04 |
Recent Filings · Page 4 of 4
31 filingsForm 4 transactions across all companies, newest first.
Showing 31–31 of 31
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.